ProfileGDS4132 / 230026_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 83% 90% 81% 95% 78% 89% 82% 82% 80% 89% 87% 85% 82% 94% 73% 81% 84% 84% 84% 93% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101297.75483
GSM201543Muscle PCOS pioglitazone 121396.99490
GSM201544Muscle PCOS pioglitazone 161298.67681
GSM201545Muscle PCOS pioglitazone 201738.19495
GSM201829Muscle PCOS pioglitazone 231270.63578
GSM201830Muscle PCOS pioglitazon 251390.87989
GSM201831Muscle PCOS pioglitazone 271301.53782
GSM201832Muscle PCOS pioglitazone 31281.0882
GSM201833Muscle PCOS pioglitazone 41270.1580
GSM201834Muscle PCOS pioglitazone 81419.9189
GSM201835Muscle PCOS after pioglitazone 102376.62887
GSM201836Muscle PCOS after pioglitazone 122344.84185
GSM201837Muscle PCOS after pioglitazone 162280.76182
GSM201838Muscle PCOS after pioglitazone 202763.97194
GSM201839Muscle PCOS after pioglitazone 232228.99473
GSM201840Muscle PCOS after pioglitazone 252305.32281
GSM201841Muscle PCOS after pioglitazone 272309.54184
GSM201842Muscle PCOS after pioglitazone 32301.56884
GSM201843Muscle PCOS after pioglitazone 42316.71384
GSM201844Muscle PCOS after pioglitazone 82594.12893